News, Articles and Updates
News
Over 1 in 4 adults with frequent mental distress can’t afford care: Report
The share of U.S. adolescents with depression fell by about a quarter in three years, to 15.4% in 2024 from 20.8% in 2021, according to Mental Health America’s “State of Mental Health in America 2026” report, released Nov. 9. Adults have not seen the same…
Mental health ranked by state
Maryland ranks No. 1 overall for mental health, a measure that combines rates of mental illness and access to care, while Nevada ranks last, according to Mental Health America’s “State of Mental Health in America 2026” report. The nonprofit ranked all 50 states and the…
Promoting Literacy to Improve Child Development: Reading Model Boosts Efforts
Reach Out and Read serves 4.8 million children, but 23% of parents at 3 centers reported clinician modeling, tied to the greatest home literacy gains. — From Psychiatric Times articles Read More
‘RHTP Funds the Setup, Not Ongoing Operations’: Bridging the Gap in Rural Behavioral Health
This is an exclusive BHB+ story. The federal Rural Health Transformation Program (RHTP) promised substantial monetary support for behavioral health and addiction treatment providers in some of the most remote parts of the country. Yet, early recipients of the funds are concerned it paves a…
NYU Langone AI tool predicts PTSD risk from ER patient narratives: Study
New York City-based NYU Langone Health researchers have developed an AI tool that predicts which emergency department trauma patients will develop post-traumatic stress disorder based on patients’ answers to the routine intake question of what brought them to the ED, according to a study published…
Texas forensic psych bed waitlist tops 1,600 amid $650M repair backlog
There were 1,626 people waiting for forensic state hospital beds at the end of fiscal year 2026, down from 1,734 in the first quarter, according to a November report from the Texas Health and Human Services Commission. The forensic waitlist covers people found incompetent to…
Compass Pathways’ psilocybin drug application heads to the FDA
Biotechnology company Compass Pathways has completed its new drug application to the FDA for COMP360, an investigational synthetic psilocybin formulation for treatment-resistant depression, the company said Nov. 9. The application rests on two phase 3 trials and a phase 2b study. Each met its primary…
Ohio warns of mislabeled cat’s claw supplements containing synthetic kratom
Ohio Gov. Mike DeWine and Attorney General Andy Wilson announced a public bulletin Nov. 6 warning that some products sold as dietary supplements, particularly those labeled as the herb cat’s claw, contain synthetic kratom and other illegal drugs. The Ohio Narcotics Intelligence Center and the…
Cannabis Use Prevalent In Substance-Related Adolescent Emergency Care: Insights From Kevin Xu, MD
New data shows cannabis dominates teens’ substance-related ER visits, often with alcohol or stimulants, urging better screening and intervention for psychosis, vomiting. — From Psychiatric Times articles Read More
Death, Taxes, and Envy: Treating Creative Patients
How can you address envy in your creative patients? — From Psychiatric Times articles Read More
The Last Times
”A tearful handshake, Steps shuffle out the doorway, My career closes…” — From Psychiatric Times articles Read More
NDA Submission Complete: COMP360 Psilocybin for Treatment-Resistant Depression
Compass Pathways has completed its submission of an NDA to the FDA for COMP360 psilocybin for treatment-resistant depression. — From Psychiatric Times articles Read More
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT